Thermo Fisher Scientific’s TaqPath Gets CE-IVD Mark to Detect Certain Viruses

Thermo Fisher Scientific received a CE-IVD mark for its TaqPath Respiratory Viral Select assay for detection of five common viruses that cause the common cold, bronchiolitis, croup, influenza-like illnesses and pneumonia.

The polymerase chain reaction (PCR) test panel, which delivers results in approximately three hours, tests for adenovirus, rhinovirus/enterovirus, parainfluenza virus and human metapneumovirus.

As the world continues to grapple with COVID-19, “offering information on these other common respiratory viruses in a single test empowers labs to detect them quickly and efficiently so that the right treatment approach can be selected," the company said. 

The TaqPath viral test panel is only available in select countries in Europe, the Middle East and Africa.